Topics

STAT Plus: Lawmakers say a Lilly program to offer half-price insulin is a bust

13:19 EST 16 Dec 2019 | STAT

Eli Lilly launched a new version of its Humalog insulin at half of the list price, a move the company claimed would help lower costs for people with diabetes. Lawmakers…

Original Article: STAT Plus: Lawmakers say a Lilly program to offer half-price insulin is a bust

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Lawmakers say a Lilly program to offer half-price insulin is a bust"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...